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Abstract
Background: Type 1 diabetes mellitus is a generally accepted atherogenic risk factor. The aim of this prospective
longitudinal study was to evaluate changes in carotid intima media thickness (cIMT) in children and adolescents
with type 1 diabetes mellitus (T1DM) using standardized methods.
Methods: We re-evaluated cIMT in 70 (38 f) of initial 150 (80 f) patients with T1DM after 4 years. At re-evaluation,
mean (± SD) age was 16.45 ± 2.59 y, mean diabetes duration was 9.2 ± 3.24 y and patients had a mean HbA1c of
8.14 ± 1.06%.
Results: Mean cIMT z-scores increased significantly during 4 years (0.58 ± 0.75, p < 0.001) as well as BMI-z-score
(0.41 ± 0.81, p < 0.01), systolic blood pressure (0.77 ± 1.15, p < 0.01) and HbA1c (0.90 ± 1.07, < 0.001). In a linear
regression model systolic blood pressure z-score at first measurement (0.02, CI: 0.01, 0.04) was a significant
predictor for the mean effect on cIMT z-score. In a logistic regression model significant risk factors for an increase
in IMT of ≥1.5 z-scores were BMI z-scores (OR: 3.02, CI:1.11, 10.14), diabetes duration (OR:1.32, CI:1.04, 1.77) and
systolic blood pressure (OR: 1.14, CI: 1.04, 1.27) at first measurement each.
Conclusions: Longitudinal cIMT measurements revealed progression in subclinical atherosclerosis during a four
year period in diabetic children and adolescents. Systolic blood pressure and BMI were related to cIMT increment.
Control of these risk factors by lifestyle and medical intervention may prevent progression of cIMT in diabetic
children.
Keywords: Intima medial thickness, subclinical atherosclerosis, Type 1 diabetes mellitus, Follow up study, cardiovas-
cular risk factors
Background
Cardiovascular disease as a result of macrovascular
atherosclerotic changes is the major cause for mortality
among patients with diabetes mellitus [1]. Even if these
complications affect predominantly the adult diabetic
patient, the process of vascular changes starts much ear-
lier. Autopsies have shown that the atherosclerotic pro-
cesses at the endothelial level begin in childhood and
progress rapidly in the presence of risk factors [2].
Thus, children with diabetes mellitus are considered as
high risk patients and special attention to vascular
health has been recommended [3].
Common carotid artery intima-media thickness
(cIMT) as measurable by high resolution B-mode ultra-
sonography is a non-invasive marker of subclinical
atherosclerosis [4]. An increased IMT has been corre-
lated to an increased relative risk for stroke and coron-
ary arterial disease in adults [5]. In children, a
significant thickening of the endothelial wall has been
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litus [6].
In the past a cross sectional study in 150 pediatric dia-
betic patients in our center revealed significantly
increased cIMT values [7]. Age at disease onset was
inversely, and HbA1c directly correlated to cIMT. A
relatively small subgroup of these patients with
increased cIMT was re-evaluated after a 2-year-interval
to elucidate preliminary data on short-term cIMT pro-
gression [8].
Now we present the results of the 4-years prospective
longitudinal cIMT assessment in the entire patient
cohort and compared them with data on classical
atherogenic risk factors available for the complete study
period. We hypothesized that with age and diabetes
duration cIMT progression take place.
Methods
From a total of 150 eligible children and adolescents
with type 1 diabetes mellitus included in the first cross
sectional study, 70 patients could be enrolled for fol-
low up. The majority of patients not included in this
study was now cared for in the adult clinic and invited
to take part in the study, but did not show up. To
exclude a selection bias we compared the previous
group of 150 patients with the remaining 70 patients
with special attention to anthropometric and metabolic
parameters. Patients enrolled only in the first measure-
ment (n = 80, 40 m) had a significantly longer diabetes
duration (7.37 ± 4.54 vs. 5.21 ± 3.29 years, p = 0.014),
higher HbA1c (7.80 ± 1.06 vs. 7.22 ± 0.73%, p = 0.01)
and a lower cIMT z-score (1.15 ± 0.58 vs. 1.82 ± 0.62,
p = 0.01).
As reported in the first study, the diagnosis of diabetes
mellitus was based on the current criteria of the Ameri-
can Diabetes Association. All patients were recruited
consecutively during their regular 3-months visits as
outpatients at our tertiary health care center (University
Children’s Hospital, Division of Endocrinology and Dia-
betology). None of the patients had evidence of retino-
pathy (as determined by dilated fundoscopy), clinical
neuropathy or overt nephropathy. Medical records were
available for all patients (data on HbA1c and insulin
dosage as well as on diabetic complications such as
microalbuminuria defined as three positive spontaneous
urine samples during the follow up visits followed by a
total of three positive 8-hours night-urine collections on
consecutive days to confirm the diagnosis, reference
range for albumin-creatinine ratio < 20 mg/g creatinine)
for the entire follow up period. Pubertal stage was
defined according to the criteria published by Tanner et
al. [9]. Waist-to-hip ratio was calculated from the waist
circumference and the hip circumference measured
according to the WHO recommendations: Waist was
measured at the level midway between the lower rib
margin and the iliac crest. Hip was measured as the
maximum circumference over the buttocks. Absolute
values were transformed in age- and sex-dependent
values. Written informed consent was obtained of all
participants from their legal guardians. The study was
performed according to the Declaration of Helsinki and
the study protocol was approved by the local ethics
committee.
Ultrasonography
As reported previously, the ultrasonographic study was
performed with the patient supine for at least 10 min-
utes in a quiet room at 22 degrees centigrade. For data
acquisition, a Philips IE33 was used equipped with a
linear 11.0 MHz transducer (Philips, Germany). All
studies were done according to a standardized scan-
ning protocol for the right and left common carotid
arteries. The common carotid artery bulb was identi-
fied and the segments of the common carotid arteries
1 to 2 cm proximal to the bulb region were scanned.
The image was focussed on the posterior - the far -
wall. Two angles were used at each side for scanning
the common carotid artery IMT: lateral and anterior-
oblique [10]. Simultaneously, an ECG tracing was
recorded. All images were obtained in the 1st and the
2nd cIMT measurement by the same single, experi-
enced ultrasonographer blinded to the patients meta-
bolic state. The images were stored digitally for
subsequent offline-analysis. For the measurement of
the cIMT, the distance in the still frame at the end of
t h ed i a s t o l e( R - w a v eo ft h eE C G )b e t w e e nt h el e a d i n g
edges of the lumen - intima interface and the media -
adventitia interface of the B-mode frame was consid-
ered. Computer software (Q l a b ,P h i l i p s ,G e r m a n y )
which analyzed the cIMT-distance automatically at 64
points within a segment of 10 mm was adopted; the
value given was the arithmetic mean cIMT calculated.
A manual second reading of the accurate border detec-
tion during computed analysis was performed in all
images obtained. The calculation of the mean cIMT
was determined from 2 separate scans of each side;
thus, the conclusive mean cIMT of each single patient
was calculated from the 4 mean cIMT-values (a total
of 256 points analyzed). In the 1
st and 2
nd cIMT mea-
surement, we calculated an intraobserver variability of
2.5% and 2.1%, respectively. The coefficient of variation
between the single measurements was 2.6%. In the 1st
measurement, we investigated also a control group (n
= 58) to assess the quality of our measurement results
and found no significant differences to normal values
from the literature. For the calculation of z-scores of
cIMT, the sex- and height-dependent normative values
from the literature were adopted [11].
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Blood pressure measurement during the regular 3-
months-follow-up visits was performed in a quiet room.
Blood pressure was obtained using a conventional oscil-
latory measurement system positioned at the right
upper arm (Dinamap, GE Systems, Germany). Measure-
ments of blood pressure were performed for each clinic
visit (3.2 ± 0.4 visits per year) and averaged for one
year. Z-scores were calculated adopting normative
values from the literature [12].
Laboratory Methods
Fasting blood samples were taken during the patients`
follow up visit. Total cholesterol, high density (HDL)
and low density cholesterol (LDL) were measured by
standard laboratory methods. Each sample was pro-
cessed immediately following the patient’sv i s i tw i t ha
maximum delay of one hour. Serum leptin levels were
measured in duplicate by RIA using commercial kits
(Human leptin RIA, Linco Research Inc., St. Charles,
MO, USA). The limit of sensitivity was 0.5 μg/L, the
intraassay CV was 8.2%, and interassay CV was 6.5%.
Adiponectin was measured by ELISA (Mediagnost, Reu-
tlingen, Germany). The limit of sensitivity was <0.6 μg/
L, the intraassay and interassay CV was < 8.5% and <
5.4%, respectively. The HbA1c level was measured by
DCA 2000 ™, based on specific inhibition of latex
immunoagglutination (Bayer AG, Leverkusen, Germany).
Normal values of HbA1c as established in our labora-
tory range from 4.0% to 6.0%. Moreover, an average
HbA1c was calculated for each patient taking the mean
of measurements (3.2 ± 0.4 visits per year) during the
previous 12 months before each cIMT measurement.
Statistics
Calculations were performed using the statistical pack-
age SPSS for Windows (version 14.0, SPSS, Chicago, IL,
USA) and R 2.12.1 (http://cran.r-project.org). Differences
within the patient group and at different time points
were examined by the non-parametric Mann-Whitney
U-test. Statistical significance was defined as p < 0.05, 2-
sided. Spearman’sr a n kc o r r e l a t i o nw a su s e dt od e t e r -
mine r values. We performed a linear regression analysis
to evaluate the associations between mean cIMT z-
scores differences between the two measurements
(dependent variable) and BMI z-scores, mean HbA1c,
diabetes duration, insulin dose, LDL cholesterol, HDL
cholesterol and systolic blood pressure (independent
variables) at first and second measurement (in separate
models). We further performed a logistic regression ana-
lysis to identify predictor variables for an increase ≥ 1.5
SD in cIMT of over time. Regression analyses were per-
formed in observations with complete information on
the dependent and all independent variables at each
measurement (n = 61). In each model, backward vari-
able selection was applied using the Akaike Information
Criterion (AIC) (13).
Results
Longitudinal data of 70 (32 m) patients could be ana-
lyzed. The characteristics of the study group at first
cIMT measurement and 4 years later are reported in
Table 1. Mean age at onset of type 1 diabetes was 7.36
± 3.78 years. All patients were on intensive insulin treat-
ment (n = 51) or on insulin pump therapy (n = 19).
At first cIMT measurement 28 (17 m) patients were
prepubertal, 42 (15 m) patients in early puberty corre-
sponding to Tanner stage 2 and 3. Patients proceeded
with pubertal development, at second measurement 28
(16 m) patients were in early or mid puberty (Tanner
stage 2 or 3), whereas 42 (16 m) patients were late or
postpubertal (Tanner stage 4 or 5 ).
During the follow up period patients had a significant
increase in mean BMI z-score (0.41, CI: 0.61, 0.21) and
mean systolic blood pressure z-score (0.77, CI: 1.06,
0.48). Regarding the metabolic profile, there was a sig-
nificant increase in mean HbA1c levels (0.90%, CI: 0.63,
1.17), whereas HDL-cholesterol (2.89 mg/dl, CI: -0.41,
6.2) and LDL-cholesterol remained stable (-2.60 mg/dl,
CI: -9.1, 3.9).
cIMT measurement
At first measurement, cIMT-z-score correlated inversely
with age at diabetes manifestation, (r = -0.42, p =
0.002). At second measurement, cIMT correlated with
the level at 1st measurement: the higher cIMT z-score
at first measurement, the higher cIMT-z-score at 2
nd
measurement (r = 0.63, p < 0.001) (Figure 1). There was
no difference between male and female patients at first
and second cIMT measurement. A major increase of ≥
1.5 SD z-scores over 4 years was developed in 14.5% of
patients (Table 2). Significant differences between the
high increase group and the remaining study population
included diabetes duration and systolic blood pressure
at first evaluation. Separating patient groups at the 2nd
cIMT measurement according to Tanner stages in early-
or midpubertal (n = 28) and late or postpubertal
patients (n = 42), those more advanced in pubertal
development had a much higher mean increase in
cIMT-z-scores than younger patients (0.80 ± 0.70 vs.
0.27 ± 0.70 SD, p < 0.05).
Classical cardiovascular risk factors
Looking for traditional cardiovascular risk factors we
compared normal weight (n = 44) and overweight
diabetic patients (BMI z-score >1.28, n = 26) at 2nd
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bution, systolic blood pressure or cIMT-z-score. In the
group of patients with adiposity (BMI z-score >2, n =
13) there were more smokers (n = 5; 33%) and a signifi-
cant difference in terms of systolic blood pressure z-
scores (1.22 ± 0.9 vs. 2.06 ± 1.38, p = 0.014) and its
increase over time (0.59 ± 1.02 vs. 1.73 ± 1.43, p =
0.004) as well as the number of patients on ACE inhibi-
tor treatment (5/13 vs.5/57). The increase in BMI-z-
s c o r ei nt h ew h o l eg r o u po fp a tients had no significant
influence on cIMT development, but was associated
with a higher increase in systolic blood pressure z-score
(r = 0.44, p = 0.01). Leptin and adiponectin had no
influence on cIMT development. At second measure-
ment 16 patients (23%) were hypertensive. Within this
group 60% were male and 27% were smokers, whereas
in the normotensive group were 10% smoker. Patients
with hypertension had a significantly higher cIMT z-
score (0.67, CI: 0.09, 1.24).
In a multivariable linear regression model for the
mean effect on cIMT z-score change HbA1c (effect per
%: -0.29, CI: -0.53, -0.05) and systolic blood pressure z-
score at first measurement (0.02, CI: 0.01, 0.04)
remained as significant predictors after backward selec-
tion. With respect to variables from second measure-
ment, the only remaining significant predictor for mean
cIMT z-score change was systolic blood pressure z-
score (0.02, CI: 0.00, 0.03) (data not shown). In logistic
regression models significant risk factors for an increase
in cIMT of ≥ 1.5 z-scores were at first measurement
BMI z-scores, diabetes duration and systolic blood pres-
sure, while at second measurement only systolic blood
pressure was borderline significant (OR: 1.07, CI: 1.00,
1.15, p = 0.05)(Table 3).
Discussion
In the present study on longitudinal evolution of carotid
intima-media-thickness in children and adolescents with
type 1 diabetes mellitus over 4 years we observed a sig-
nificant progression in carotid IMT z-scores. We
assume a promoting and accelerating effect of known
cardiovascular risk factors on cIMT.
Macrovascular disease leading to cardiovascular com-
plications remains the endpoint of type 1 diabetes melli-
tus in adulthood [1]. Atherosclerotic lesions develop
slowly, but continuously leading to the main causes of
mortality in diabetic patients such as coronary arterial
disease, stroke, and renal failure [13]. In diabetic chil-
dren, the presence of subclinical atherosclerotic disease
as a precursor of macrovascular complications has been
shown in several studies [6]. Also, impaired endothelial
function preceding atherosclerotic changes has been
observed [14]. As the measurement of the intima-media
thickness of the carotid arteries is considered a surro-
gate marker of subclinical atherosclerosis, this method
has been used widely in these patients to asses vascular
health [6]. According to the results of several cross-sec-
tional studies, evidence for an increased cIMT and aor-
tic IMT in diabetic children emerged [6,15]. Data from
observations on the cIMT in adult patients indicated
Table 1 Characteristics of the study population of patients with Type 1 diabetes mellitus
1
st cIMT measurement (n = 70) 2
nd cIMT measurement (n = 70) p-value of change
Age (years) 12.61 ± 2.49 16.45 ± 2.59 <0.001
Diabetes duration (years) 5.20 ± 3.31 9.21 ± 3.24 <0.001
Height (cm) 156.21 ± 16.51 170.1 ± 11.83 <0.001
Weight (kg) 50.58 ± 16.68 67.57 ± 14.79 <0.001
BMI (kg/m
2) 20.15 ± 3.56 23.17 ± 3.53 <0.001
BMI z-score 0.45 ± 0.94 0.86 ± 1.10 <0.001
Waist hip ratio n.a. 0.57 ± 1.40
Systolic blood pressure (mmHg) 109.27 ± 10.68 122.47 ± 11.50 <0.001
Systolic blood pressure z-score 0.59 ± 0.80 1.37 ± 1.05 <0.001
LDL-cholesterol (mg/dl) 88.30 ± 24.71 85.87 ± 27.75 0.43
HDL-cholesterol (mg/dl) 60.04 ± 15.61 63.25 ± 15.43 0.085
HbA1c (%) 7.24 ± 0.74 8.14 ± 1.06 <0.001
Insulin dose (IU/kg body weight/day) 0.81 ± 0.32 0.98 ± 0.26 <0.001
Microalbuminuria (number of patients) 4 5 0.322
Antihypertensive treatment (number of patients) 1 10 0.002
Smoking (number of patients 1 10 0.004
cIMT (mm) 0.469 ± 0.031 0.478 ± 0.031 <0.001
cIMT z-score 1.86 ± 0.61 2.44 ± 1.00 <0.001
Data are means ± SD; cIMT carotid intima medial thickness; BMI body mass index; LDL low density lipoprotein cholesterol; HDL high density lipoprotein
cholesterol.
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vated cardiovascular risk factors like hypercholesterole-
mia, glycemic control or obesity are optimized [16].
This has been shown also in selected pediatric patient
groups including children with hypercholesterolemia or
overweight [16,17]. Even if recently a metaanalysis
raised concerns on the ability of cIMT regression to
predict reduction of cardiovascular events, several
research groups recommended longitudinal cIMT
assessment [18].
In a previous cross sectional study in children and
adolescents with type 1 diabetes, we were able to show
that cIMT is elevated in comparison to a healthy control
group and to normative data. We proposed longitudinal
cIMT measurements to elucidate more details on the
individual cardiovascular risk based on the cIMT evolu-
tion [7]. Subsequently, we followed a selected subgroup
of diabetic patients with elevated cIMT over 2 years [8].
Now, we present the results of a 4-year longitudinal
prospective study in a cohort of 70 patients.
Within the patient group, we observed an individual
increase of cIMT z-scores over 4 years. Thus, not only
vascular health, but also vascular aging seems to be
affected in diabetic children [19]. In concordance with
adult patients data, also in diabetic children endothelial
changes seem to be accelerated compared to normal
values [20]. Interestingly, patients with elevated cIMT at
baseline were more prone to accelerated vascular aging
during the follow up period.
The association between cIMT and diabetes duration
and age at manifestation was found by us and by other
research groups [13,21]. Conversely, one group observed
only aging, but not diabetes duration as a relevant factor
for IMT increase[22]. Longer disease duration early in
life might enhance the metabolic effects of diabetes on
the vascular system and result in earlier onset and
Figure 1 Close association of cIMT measurements at baseline and after 4 years, solid line represents the fit line at total and broken
line represents the reference line from the equation y = x.
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Page 5 of 8Table 2 Characteristics of patients with a major increase in IMT z-scores of ≥ 1.5 SD over 4 years in comparison to the
remaining patients
cIMT- z-score increase ≥1.5 SD (n
= 11)
cIMT z-score increase < 1.5 SD (n
= 55)
p-value of mean
difference
Age_2 (at 2
nd cIMT measurement) (years) 17.59 ± 2.87 16.08 ± 2.48 0.078
Age at disease manifestation (years) 6.97 ± 4.02 7.44 ± 3.77 0.71
Diabetes duration_2 10.85 ± 3.92 8.77 ± 2.93 0.047
Puberty_2 (early-mid pubertal/late or
postpubertal)
2/9 25/30 0.096
Microalbuminuria and ACEi treatment_2
(patients)
4 11 0.42
Smoking_2 (patients) 2 8 0.741
HbA1c_1 (1
st measurement) (%) 6.99 ± 0.51 7.27 ± 0.77 0.250
HbA1c_2 (%) 7.60 ± 0.77 8.23 ± 1.08 0.085
LDL-cholesterol_2 (mg/dl) 84.27 ± 23.11 86.73 ± 28.66 0.79
HDL-cholesterol_2 (mg/dl) 65.27 ± 16.30 62.69 ± 15.52 0.62
Leptin (μg/L) 11.51 ± 6.32 8.08 ± 8.03 0.219
Adiponectin (μg/L) 12.69 ± 5.74 13.54 ± 4.13 0.619
Systolic blood pressure_1 (mmHg) 116.50 ± 8.86 107.81 ± 10.31 0.011
Systolic blood pressure_1 z-score 0.99 ± 0.95 0.49 ± 0.74 0.056
Systolic blood pressure_2 (mmHg) 128.20 ± 12.30 121.41 ± 11.15 0.086
Systolic blood pressure_2 z-score 1.77 ± 1.28 1.29 ± 1.03 0.192
BMI_1 z-score 0.82 ± 0.95 0.33 ± 0.88 0.796
BMI_2 z-score 0.91 ± 1.03 0.82 ± 1.10 0.103
cIMT-1 z-score 2.13 ± 0.48 1.81 ± 0.62 0.578
cIMT-2 z-score 3.83 ± 0.43 2.16 ± 0.84 <0.001
Data are means ± SD; cIMT carotid intima medial thickness; ACEi angiotensin converting enzyme inhibitor; LDL low density lipoprotein cholesterol; HDL high
density lipoprotein cholesterol; BMI body mass index.
Table 3 Linear regression on mean change in cIMT and logistic regression model on the risk to develop a major
increase in cIMT z-scores of ≥ 1.5:
Prediction based on parameters at first measurement Prediction based on parameters at first measurement
Full model linear regression Full model logistic regression
Predictor OR [95%-CI] p-value Predictor OR [95%-CI] p-value
BMI z-scores 0.04 [-0.17, 0.26] 0.7 BMI z-scores 2.78 [0.97, 9.69] 0.07
Mean HbA1c -0.26 [-0.51, -0.01] 0.04 Mean HbA1c 0.33 [0.06, 1.36] 0.15
Diabetes duration -0.02 [-0.08, 0.04] 0.47 Diabetes duration 1.40 [1.07, 2.00] 0.03
Insulin dose -0.34 [-0.93, 0.24] 0.24 Insulin dose 0.46 [0.03, 6.45] 0.57
LDL-cholesterol 0.00 [-0.01, 0.01] 0.71 LDL-cholesterol 1.02 [0.99, 1.06] 0.28
HDL-cholesterol -0.01 [-0.02, 0.00] 0.17 HDL-cholesterol 0.99 [0.92, 1.05] 0.65
Sys. blood pressure 0.02 [0.01, 0.04] <0.01 Sys. blood pressure 1.15 [1.04, 1.31] 0.01
Selected variables according to AIC Selected variables according to AIC
HDL-cholesterol -0.01 -[0.02, 0.00] 0.14 Mean HbA1c 0.29 [0.04, 1.11] 0.10
Mean HbA1c -0.29 [-0.53, -0.05] 0.02 Diabetes duration 1.32 [1.04, 1.77] 0.03
Sys. blood pressure 0.02 [0.01, 0.04] 0.01 Sys. blood pressure 1.14 [1.04, 1.27] <0.01
BMI z-score 3.02 [1.11, 10.14] 0.046
BMI body mass index; LDL low density lipoprotein cholesterol; HDL high density lipoprotein cholesterol; sys systolic; AIC Akaike Information Criterion
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with increasing age other classical cardiovascular risk
factors may play an additional role in diabetic children.
We observed an association of systolic blood pressure,
diabetes duration and BMI with mean increase in IMT
z-scores in linear regression analysis: For example, an
increase in systolic blood pressure by 1 mmHg was
associated with a mean increase in IMT-z-scores of
0.02. Further, children with longer disease duration had
increased risk to show a major increase in cIMT (36%
per year). Even more impressive was the influence of
the BMI z-score at first measurement, increasing the
risk to develop a major augmentation in cIMT z-scores
by the factor 3.02. As resulting from the literature, the
association of several cardiovascular risk factors seems
to add deleterious effects to the vascular bed in diabetic
children [23]. Recently, also postprandial glucose levels
have been found to be correlated to cIMT [24]. Thus,
current recommendations for the medical care of dia-
betic children include lower thresholds for blood pres-
sure and BMI compared to healthy children [3]. Also in
non-diabetic adolescents, the combination of systolic
blood pressure, LDL-cholesterol, smoking and BMI
measured at the age of 12 to 18 years were associated
with adult cIMT [25]. Surprisingly, HbA1c was nega-
tively associated with cIMT increment. This might be
explained by a possibly higher rate of hypoglycemia and
their deleterious effect on the endothelium. According
to the recent publication by Wright et al. hypoglycemia
triggers the expression of vasoactive substances (CD 40,
soluble CD 40 ligand), markers of inflammation, throm-
bosis and endothelial dysfunction [26].
Within the study group, patients developed higher
BMI z-scores. This is in accordance with other studies
on weight and BMI development in children and adoles-
cents with diabetes type 1 [23]. The BMI as mentioned
above played a major role in cIMT development. In the
entire group, systolic blood pressure, LDL z-scores,
HbA1c levels, and insulin requirement progressed. Also,
the number of smokers increased. As known from adult
patients, components of the metabolic syndrome contri-
bute to accelerated early atherosclerosis. Leptin and adi-
ponectin levels, though elevated throughout the study
group, failed to show any correlation to cIMT values.
Thus, in our patients, these hormones seem not to play
a key role as mediators of vascular damage in visceral
adiposity. So, we may not propose to investigate on lep-
tin and adiponectin levels in diabetic children for the
assessment of vascular health so far [27].
The majority of patients showed a cIMT z-score
increment during pubertal development. This is in
accordance with Wiegman et al. who found a significant
deviation in cIMT at the age of 12 years in children
with familial hypercholesterolemia compared to
unaffected siblings [28]. Adolescence has been identified
as a critical time in determining risk factors of future
vascular complications in type 1 diabetes mellitus [29].
Interventions to prevent these complications may be
most efficient if implemented at a young age before
puberty. Early cIMT measurement possibly could help
to identify diabetic patients at risk to develop cIMT
increment, followed by individualized care to optimize
the metabolic profile (e.g. BMI) and blood pressure dur-
ing puberty. Interestingly, we could not find gender dif-
ferences in cIMT values in our patients. We speculate
that the influence of sexual hormones on the cIMT is
minimal in adolescence and early adulthood; supported
by the fact that normal values on cIMT in this age
group are similar for males and females [11].
Some limitations of our study have to be addressed.
An observational study cannot establish causality. Our
measurement method differs from some other research
groups; but according to the actual recommendations
semi automated border detection software is the best
solution for cIMT measurement up to date. Also, the
normative data adopted were obtained by the same
method and protocol [11]. Furthermore, we were able to
demonstrate excellent intra-observer reliability for our
cIMT measurement. A further limitation is the loss-to-
follow-up of 80 pts. However, the presented cohort is
representative in number and may show more pro-
nounced influencing factors, though it had higher cIMT
z-scores initially.
Conclusion
Concluding, the results of our study indicate that children
and adolescents with type 1 diabetes mellitus show
increased cIMT values also after a period of 4 years.
Patients with increased cIMT at baseline show a further
acceleration in cIMT increment indicating that vascular
changes continue to evolve throughout puberty and ado-
lescence. In a multivariate logistic regression model systo-
lic blood pressure, diabetes duration and BMI were
associated with major cIMT increment. So, we propose to
optimize blood pressure levels and BMI development as
early as possible in diabetic children to prevent long-term
vascular damage. Further studies addressing the effect of
interventional programmes on the cIMT are warranted.
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